Zura Bio
Gary Whale is currently the Chief Technology Officer at Zura Bio Limited, a clinical-stage biotechnology company. Prior to this role, Gary held positions such as VP & Global Head of Technical Operations at EUSA Pharma, Chief Operating Officer at VHsquared Ltd., and Senior Director of Product Development at Emergent BioSolutions. Gary has a strong background in process and analytical development within the biopharmaceutical industry and holds a PhD in Purification & Characterisation of Lipid Macroamphiphiles from Robert Gordon University.
This person is not in any offices
Zura Bio
1 followers
Zura Bio is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders. Currently, Zura Bio is developing three assets which have completed phase 1/1b studies and are Phase 2 ready. The company is developing a portfolio of therapeutic indications for tibulizumab (ZB-106), torudokimab (ZB-880), and ZB-168 with a goal of demonstrating their efficacy, safety, and dosing convenience in immune and inflammatory disorders. Zura Bio is headquartered in Henderson, NV with team members in the UK and USA.